The rapid microbiology testing solutions market offers significant growth opportunities driven by increasing regulatory acceptance, demand for faster product release, and technological advances. The ...

Safety and efficacy are the two regulatory benchmarks for pharmaceutical products. Microbial contamination of products is an important aspect of product quality that can affect both safety and ...

If you would like to learn more about the IAEA’s work, sign up for our weekly updates containing our most important news, multimedia and more.

A rapid microbiological point-of-care test designed to help GPs identify whether a respiratory infection is caused by a virus did not lead to an expected overall reduction in same-day antibiotic ...